Overall, these results demonstrate that PRMT1 promotes RPL29 gene transcription via catalyzing H4R3me2a at its gene promoter in CML LSCs. This evidence concerns the gene PRMT1 and chronic myelogenous leukemia, BCR-ABL1 positive.